Zhongguo quanke yixue (Dec 2024)
Exploration and Practice of the Construction of Outpatient Model for Blood Lipid Management in Comprehensive Hospitals
Abstract
Background Cardiovascular disease, mainly atherosclerotic cardiovascular disease, is the first cause of death for urban and rural residents in China. Low density lipoprotein cholesterol is the pathogenic risk factor of ASCVD. Objective By establishing a new outpatient model for blood lipid management, to analyze the awareness rate of abnormal blood lipids in patients before and after the establishment of the new model, the proportion of rational drug use, patient compliance, and medication compliance rate. Methods From September 1, 2023 to February 28, 2024, has established a comprehensive outpatient model for managing blood lipid abnormalities based on scientific research projects by integrating medical resources. The model takes the outpatient service of "patients with dyslipidemia" as the carrier, and collaborates with specialized doctors and general practitioners to standardize the management of dyslipidemia patients, optimize the consultation and follow-up process, effectively screen the population with dyslipidemia, diagnose hyperlipidemia patients, and provide correct treatment methods. Results The model of patients with dyslipidemia included in the management of chronic diseases has shifted from a dispersed model to a comprehensive, standardized, and centralized management of lipid management outpatient services, and the number of patients managed has significantly increased compared to before. The proportion of standardized medication for first-time patients in our blood lipid management outpatient department has increased from 25.3% (147/580) to 30.3% (242/798), the proportion of adherence to medication has increased from 32.7% (190/580) to 41.6% (332/798), and the compliance rate of medication has increased from 15.8% (92/580) to 22.5% (180/798) (P<0.05) . Conclusion Through the implementation of the "comprehensive and specialized" prevention and treatment model, the number of patients with dyslipidemia included in chronic disease management has significantly increased, and the proportion of standardized medication, medication compliance, and medication compliance rate have been improved. The model not only cultivates talents while implementing scientific research projects, but also enhances the research capabilities and professional service levels of general practitioners, graduate students, and regulatory trainees.
Keywords
